Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. A pilot study in The Journal of Molecular Diagnostics, published by Elsevier, ...

RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer. Results point to the possibility of future clinical trials in this disease ...

RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer. Results point to the possibility of future clinical trials testing neoadjuvant ...

Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous leukemia, reports ...

5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Pharmacodynamic ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Design by: Anna Deyoung In a recent study by University of Michigan and other institutions, ...

Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using industry-leading ...

Proteins floating in the cerebrospinal fluid might do more than diagnose Alzheimer’s disease—they may identify different subtypes, according to researchers led by Betty Tijms of the Amsterdam ...

SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc.

An international team of neuroscientists has for the first time identified five distinct subtypes of Alzheimer’s disease, in what could be a breakthrough for treatment approaches and efficacy. They ...